Neuren Pharmaceuticals Ltd (NEU.AX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 3,153 | 17,094 | 40,180 | 36,783 | 24,188 |
| Marketable Securities | 219,089 | 211,445 | N/A | N/A | N/A |
| Receivables | 157,570 | 14,412 | 1,089 | 1,424 | 755 |
| Other current assets | 19,118 | 0 | 0 | 0 | 0 |
| TOTAL | $399,327 | $247,156 | $43,246 | $40,044 | $24,943 |
| Non-Current Assets | |||||
| PPE Net | 31 | 43 | 21 | 12 | 10 |
| Other Non-Current Assets | 10,348 | 771 | 0 | 0 | 0 |
| TOTAL | $10,379 | $814 | $21 | $12 | $10 |
| Total Assets | $409,706 | $247,970 | $43,267 | $40,056 | $24,953 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,449 | 675 | 258 | 245 | 167 |
| TOTAL | $45,761 | $42,763 | $1,678 | $803 | $753 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 41 | 0 | 0 | 0 | 0 |
| TOTAL | $41 | $0 | $0 | $0 | $0 |
| Total Liabilities | $45,802 | $42,763 | $1,678 | $803 | $753 |
| Shareholders' Equity | |||||
| Common Shares | 165,270 | 173,127 | 167,740 | 167,578 | 145,567 |
| Retained earnings | 180,431 | 38,388 | -118,693 | -118,877 | -111,083 |
| Other shareholders' equity | 18,203 | -6,308 | -7,458 | -9,448 | -10,284 |
| TOTAL | $363,904 | $205,207 | $41,589 | $39,253 | $24,200 |
| Total Liabilities And Equity | $409,706 | $247,970 | $43,267 | $40,056 | $24,953 |